RBFOX3 and craniosynostosis: The proportion of Neun+ cells was 38.2% ± 3.1% in the MCAO-Con group (##p < 0.01 vs. Sham-Con group), and CSO treatment significantly increased the proportion of Neun+ cells to 65.5% ± 3.2% (*p < 0.05 vs. MCAO-Con group).